In this study we further show that CF101, an A3AR agonist, inhibits the growth of colon carcinoma cells both in vitro and in vivo, and that in addition to the direct antiproliferative effect an immunomodulatory mechanism is involved. The gene discussed is ADORA3; the disease is colon carcinoma.